Ebola Vaccine

The recent ebola outbreak in west Africa has stressed the need for advances in research to develop a vaccine against this deadly virus. Much progress has been made in pre-clinical and clinical studies and future vaccines for the ebola virus look promising. Here is the latest research on ebola vaccines.

January 12, 2021

Effect of a bundle approach on external ventricular drain-related infection

Acta neurochirurgica
Bujung HongJoachim K Krauss
January 9, 2021

COVID-19 in Africa: the little we know and the lot we ignore

Epidemiologia e prevenzione
Sandro ColomboAmélia Jossai Cumbi
January 9, 2021
Open Access

Use of Ebola Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020

MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports
Mary J ChoiSharon E Frey
January 11, 2021
Review
Open Access

An Ophthalmologist's Insight Into The Viral Pandemics

Journal of Optometry
Rebika DhimanRohit Saxena
January 19, 2021
Preprint
Open Access

Rapid protection from COVID-19 in nonhuman primates vaccinated intramuscularly but not intranasally with a single dose of a recombinant vaccine

BioRxiv : the Preprint Server for Biology
W. FuruyamaAndrea Marzi
January 23, 2021
Review
Open Access

SARS-CoV-2 Cellular Infection and Therapeutic Opportunities: Lessons Learned from Ebola Virus.

Membranes
Jordana Muñoz-BasagoitiNuria Izquierdo-Useros
January 12, 2021
Open Access

Ebola virus disease surveillance in the absence of a confirmed case; the case of the Rwenzori region of Uganda

The Pan African Medical Journal
Emmanuel Angmorteh MensahSamuel Ofori Gyasi
January 12, 2021

Life-Saving Procedures Performed While Wearing CBRNe Personal Protective Equipment: A Mannequin Randomized Trial

Simulation in Healthcare : Journal of the Society for Simulation in Healthcare
Giulia MormandoFabrizio Fabris
January 9, 2021
Preprint

Ribonucleic acid (RNA) virus and coronavirus in Google Dataset Search: their scope and epidemiological correlation

ArXiv
Manuel Blázquez-Ochando, Juan-José Prieto-Gutiérrez
January 12, 2021
Open Access

The armed forces health service in the face of major health risks

Éthique & Santé
C BoulliatB Massoubre
January 13, 2021
Review
Open Access

REGN-EB3: First Approval

Drugs
Anthony Markham
January 12, 2021
Open Access

Lessons Learned in Infection Prevention for Ebola Virus Disease and the COVID-19 Pandemic-Principles Underlying Prevention

Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Erica S Shenoy, David J Weber
January 12, 2021
Open Access

Age Differences in Preferences for Fear-Enhancing Vs. Fear-Reducing News in a Disease Outbreak

Frontiers in Psychology
Anthony A VillalbaMichelle L Houston
January 20, 2021

Mining of Ebola virus genome for the construction of multi-epitope vaccine to combat its infection

Journal of Biomolecular Structure & Dynamics
Uma ShankarAmit Kumar
January 22, 2021
Review
Open Access

Lessons from the host defences of bats, a unique viral reservoir.

Nature
Aaron T IrvingLin-Fa Wang

Sign up to follow this feed and discover related papers.

Related Feeds

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Acute viral rhinopharyngitis

Acute viral rhinopharyngitis, also known as "common cold", is an acute, self-limiting viral infection of the upper respiratory tract involving the nose, sinuses, pharynx and larynx. Discover the latest research on acute viral rhinopharyngitis here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

© 2021 Meta ULC. All rights reserved
/feed-previews/ebola-vaccine/e7756758-7483-4783-8f77-3b5ca9ece6a4